"Das Kantonsspital Münsterlingen ist ein Unternehmen der Spital Thurgau AG. Wir sind ein Akutspital mit rund 300 Betten, bieten ein umfassendes Leistungsangebot und investieren stetig in unsere hochwertige Infrastruktur. Wir bieten attraktive Arbeitsumgebungen, interdisziplinäre Zusammenarbeit und gezielte Entwicklungsmöglichkeiten. Zur erfolgreichen Spital Thurgau AG zählen rund 3'500 Mitarbeitende an verschiedensten Unternehmensstandorten."

During the past decade, Kantonsspital Münsterlingen conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kantonsspital Münsterlingen" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 7 trials, followed by "Kantonsspital Münsterlingen" with 2 trials sponsored, "University Hospital Inselspital, Berne" with 2 trials sponsored, "David Scheiner" with 1 trials sponsored and "Gustave Roussy, Cancer Campus, Grand Paris" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Münsterlingen" #1 collaborator was "Cantonal Hospital of St. Gallen" with 2 trials as a collaborator, "Kantonsspital Münsterlingen" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator, "Anticancer Fund, Belgium" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Kantonsspital Münsterlingen" are "Prostate Cancer" (5 trials), "ARDS, Human" (1 trials), "Acute Stroke" (1 trials), "Arthropathy of Hip" (1 trials) and "Arthropathy of Knee" (1 trials). Many other conditions were trialed in "Kantonsspital Münsterlingen" in a lesser frequency.

Most popular intervention types in "Kantonsspital Münsterlingen" are "Drug" (11 trials), "Other" (3 trials), "Radiation" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Orteronel" (2 trials), "Acetylsalicylic acid" (1 trials), "Atorvastatin" (1 trials) and "Denosumab (reduced dosing)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kantonsspital Münsterlingen" are 11 trials for "All" genders, 5 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Kantonsspital Münsterlingen". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kantonsspital Münsterlingen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kantonsspital Münsterlingen, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".